152 related articles for article (PubMed ID: 36958405)
1. A feline model of spontaneously occurring autoimmune limbic encephalitis.
Glantschnigg-Eisl U; Klang A; Kneissl S; Lang B; Waters P; Irani SR; Binks SNM; Pakozdy A
Vet J; 2023; 296-297():105974. PubMed ID: 36958405
[TBL] [Abstract][Full Text] [Related]
2. Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody.
Pakozdy A; Halasz P; Klang A; Bauer J; Leschnik M; Tichy A; Thalhammer JG; Lang B; Vincent A
J Vet Intern Med; 2013; 27(1):212-4. PubMed ID: 23278981
[TBL] [Abstract][Full Text] [Related]
3. Parallel roles of neuroinflammation in feline and human epilepsies.
Binks S; Lamquet S; Crawford AH; Meurs A; Irani SR; Pakozdy A
Vet J; 2022 Dec; 290():105912. PubMed ID: 36209994
[TBL] [Abstract][Full Text] [Related]
4. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
Malter MP; Frisch C; Schoene-Bake JC; Helmstaedter C; Wandinger KP; Stoecker W; Urbach H; Surges R; Elger CE; Vincent AV; Bien CG
J Neurol; 2014 Sep; 261(9):1695-705. PubMed ID: 24935858
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
6. EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis.
Pakozdy A; Glantschnigg U; Leschnik M; Hechinger H; Moloney T; Lang B; Halasz P; Vincent A
Epileptic Disord; 2014 Mar; 16(1):116-20. PubMed ID: 24667692
[TBL] [Abstract][Full Text] [Related]
7. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
8. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
[TBL] [Abstract][Full Text] [Related]
9. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.
Lai M; Huijbers MG; Lancaster E; Graus F; Bataller L; Balice-Gordon R; Cowell JK; Dalmau J
Lancet Neurol; 2010 Aug; 9(8):776-85. PubMed ID: 20580615
[TBL] [Abstract][Full Text] [Related]
10. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
12. Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
Ludewig S; Salzburger L; Goihl A; Rohne J; Leypoldt F; Bittner D; Düzel E; Schraven B; Reinhold D; Korte M; Körtvélyessy P
Cells; 2023 Jan; 12(2):. PubMed ID: 36672216
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
14. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
16. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis.
Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y
Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820
[TBL] [Abstract][Full Text] [Related]
18. A Chinese female patient with LGI1 and mGluR5 antibodies: A case report.
Huo T; Luo X; Zhao J; Wang T; Chen J
Medicine (Baltimore); 2022 Oct; 101(43):e31063. PubMed ID: 36316880
[TBL] [Abstract][Full Text] [Related]
19. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
[TBL] [Abstract][Full Text] [Related]
20. Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
Schimmel M; Frühwald MC; Bien CG
Eur J Paediatr Neurol; 2018 Jan; 22(1):190-193. PubMed ID: 28919330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
